Not Rated
|
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 04-Nov-25 | 9939.40 | -0.61% | - | 0.20% | 190/230 |
| 1 Month | 10-Oct-25 | 10098.30 | 0.98% | - | 1.51% | 145/227 |
| 3 Month | 12-Aug-25 | 10288.40 | 2.88% | - | 5.32% | 194/224 |
| 6 Month | 12-May-25 | 11256.70 | 12.57% | - | 8.57% | 31/213 |
| YTD | 01-Jan-25 | 10417.60 | 4.18% | - | 5.47% | 102/201 |
| 1 Year | 12-Nov-24 | 11140.60 | 11.41% | 11.41% | 6.97% | 44/187 |
| Since Inception | 06-Feb-24 | 14592.00 | 45.92% | 23.84% | 14.38% | 16/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 12-Nov-24 | 12000 | 13028.12 | 8.57 % | 16.18 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 375.2 | 7.82% | 0.00% | 11.31% (Apr 2025) | 6.09% (Aug 2025) | 2.22 L | 32.89 k |
| # Divis Laboratories Ltd. | Pharmaceuticals | 329.6 | 6.87% | 0.00% | 7.76% (May 2025) | 2.28% (Aug 2025) | 48.92 k | 27.34 k |
| # J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 311.3 | 6.48% | 0.00% | 6.94% (Sep 2025) | 0% (Oct 2024) | 1.85 L | 5.43 k |
| # Fortis Healthcare Ltd. | Hospital | 303.5 | 6.32% | 0.00% | 6.69% (Sep 2025) | 1.84% (Oct 2024) | 2.97 L | -8.55 k |
| # Laurus Labs Ltd. | Pharmaceuticals | 224.6 | 4.68% | 0.00% | 4.44% (Jul 2025) | 0.79% (Oct 2024) | 2.36 L | 10.34 k |
| # Cipla Ltd. | Pharmaceuticals | 201.4 | 4.20% | 0.00% | 8.07% (Feb 2025) | 4.56% (Sep 2025) | 1.34 L | 0.00 |
| # Neuland Laboratories Ltd. | Pharmaceuticals | 183.6 | 3.82% | 0.00% | 3.2% (Sep 2025) | 1.3% (Feb 2025) | 11.14 k | 1.45 k |
| # Lupin Ltd. | Pharmaceuticals | 179.2 | 3.73% | 0.00% | 5.58% (Mar 2025) | 1.15% (Jul 2025) | 91.24 k | 18.56 k |
| # Sai Life Sciences Ltd. | Petrochemicals | 141.3 | 2.94% | 0.00% | 2.89% (Sep 2025) | 0% (Oct 2024) | 1.54 L | 5.35 k |
| # Krishna Institute of Medical Sciences Ltd. | Hospital | 131 | 2.73% | 0.00% | 4.09% (Sep 2025) | 2.63% (Oct 2024) | 1.82 L | -0.77 L |
Investment / Portfolio Grades
| Security Type |
% Weight |
Category Average |
|---|---|---|
| Government Backed | 3.67% | 0.44% |
| Low Risk | 0.00% | 0.00% |
| Moderate Risk | 0.00% | 0.00% |
| High Risk | 0.00% | 0.00% |
| Very High Risk | 0.00% | 0.00% |
| Others | 0.00% | 0.00% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 5.50% |
| Net Receivables | Net Receivables | -0.05% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 1.03 | 16.25 | 53.74 | 44.73 | 38.77 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 2.49 | 4.87 | 19.26 | 30.41 | 16.95 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.48 | 8.62 | 20.77 | 25.20 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | 1.11 | 12.15 | 24.63 | 24.32 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 2.35 | 11.50 | 20.87 | 24.06 | 15.08 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 2.43 | 4.70 | 13.50 | 20.74 | 18.45 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 4.18 | 8.60 | 8.34 | 20.47 | 15.36 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 3.01 | 7.70 | 8.60 | 20.08 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 0.39 | 8.71 | 16.54 | 19.88 | 0.00 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 3.08 | 6.60 | 10.74 | 19.34 | 20.51 |
Out of 19 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 2 is/are ranked 4 * , and 15 schemes are not ranked. See more about AMC